)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Avid Bioservices (CDMO) investor relations material
Avid Bioservices Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary10 Dec, 2024
Executive summary
Revenues for Q2 FY2025 were $33.5 million, up 32% year-over-year, and $73.7 million for the six months, driven by higher manufacturing and process development revenues.
Backlog rose to $220 million at quarter-end, up 11% year-over-year, with significant revenue recognition expected over the next five quarters.
Net loss for Q2 FY2025 was $17.4 million ($0.27/share), and $22.9 million ($0.36/share) for the six months, reflecting increased SG&A and interest expenses.
On November 6, 2024, a definitive merger agreement was signed for acquisition by affiliates of GHO Capital Partners LLP and Ampersand Capital Partners, with shareholders to receive $12.50 per share in cash, a 13.8% premium to pre-announcement price.
The all-cash transaction is valued at $1.1 billion and is expected to close in Q1 2025.
Financial highlights
Q2 FY2025 revenues increased to $33.5 million from $25.4 million year-over-year; manufacturing revenues rose by $7.1 million and process development revenues by $0.9 million.
Gross loss for Q2 FY2025 was $2.0 million (negative 6% margin), improved from a $4.7 million loss (negative 18% margin) in the prior year.
SG&A expenses rose to $10.6 million, up 61% year-over-year, mainly due to higher compensation, benefits, and legal fees.
Cash and cash equivalents at October 31, 2024, were $33.4 million, down from $38.1 million at April 30, 2024.
Company’s revolving line of credit expired during the quarter.
Outlook and guidance
Management expects existing cash and anticipated operating cash flows to fund operations for at least the next 12 months.
Financial guidance is suspended due to the pending acquisition.
Significant portion of backlog expected to convert to revenue over the next five fiscal quarters.
Short-term capital expenditures for fiscal 2025 are projected at $5–$7 million.
During the merger pendency, the company is restricted from raising capital or making significant operational changes outside the ordinary course.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO) that provides specialized services for the biotechnology and biopharmaceutical industries. The company focuses on biologics, offering process development, clinical and commercial Current Good Manufacturing Practice (CGMP) manufacturing, and related services. These include bulk packaging, release and stability testing, regulatory support, upstream and downstream process optimization, analytical methods development, and cell line development. Avid supports projects from early preclinical stages to commercial-scale production. Its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage